IMS Health estimates that the top 5 countries, South Africa, Egypt, Algeria, Morocco and Nigeria account for 70% of the value of pharmaceutical markets in Africa. The rest of the continent, without the Top 5 (50 markets) makes up 30% of the total value.
| Rank | US$ Million | 2009 | 2014 | CAGR 09 - 14 |
| 1 | South Africa | 3 014 | 4 902 | 10% |
| 2 | Egypt | 2 402 | 3 868 | 10% |
| 3 | Algeria | 2 175 | 3 548 | 10% |
| 4 | Morocco | 1 197 | 1 842 | 9% |
| 5 | Nigeria | 926 | 1 237 | 6% |
| Total Top 5 | 9 714 | 15 397 | 10% | |
| Africa w/o Top 5 markets | 4 165 | 5 537 | 6% | |
| French W. Africa | 667 | 892 | 6% | |
| Tunisia | 650 | 945 | 8% | |
| Kenya | 234 | 329 | 7% | |
| Tanzania | 194 | 262 | 6% | |
| Total Africa | 13 879 | 20 934 | 9% |
Source: IMS Health 2010 - Global Market Prognosis 2010-2014.
Find out the status of the pharmaceutical markets in different African countries at theEuro-Africa Health Investment Conference:MediPharm
14 years ago
